Слайд 2
Neuroleptics (Antipsychotic Drugs)
Слайд 3
MECHANISM OF ACTION:
blockade of dopamine D2-receptors
IN PERIPHERY
:
BLOCK :
M - Cholinoreceptors
α - Adrenoreceptors
H1- Histamine Receptors
Serotonin (5-HT) Receptors
DIRECT SPASMOLYTIC ACTION
Слайд 4
Pharmacological Effects:
Antipsychotic Actions:
⇓ Hallucination and Agitation
Antiemetic Effects
Extrapyramidal
Effects:
D2-Rs blockade in the Nigrostriatal Pathways => =>
Parkinsonian Symptoms
Anti-muscarinic Effects:
Blurred Vision, Dry Mouth, Sedation, Confusion, Inhibition of GIT and Urinary Smooth Muscles
Слайд 7
Extrapyramidal Еffects:
due to Blocking of D2 receptors
in the Nigrostriatal Pathway:
Parkinsonian Symptoms
Akathisia (Motor
Restlessness) - the inability to sit still
because of Uncontrollable Movement
Tardive Dyskinesia: Inappropriate Postures of the Neck, Trunk, and Limbs
Malignant Neuroleptic Syndrome:
Skeletal Muscle Rigidity, Hyperthermia, Stupor
Слайд 8
Clinical Uses of Neuroleptics
1. SCHIZOPHRENIA:
Positive Symptoms
of Schizophrenia : DELUSIONS, HALLUCINATIONS and THOUGHT DISORDERS
Negative Symptoms
of Schizophrenia: withdrawal,
blunted emotions, reduced ability to relate to people
2. PREVENTION OF SEVERE NAUSEA and VOMITING: Drug-induced nausea
3. OTHER USES: treatment of DRUG ADDICTION, NEUROLEPTANESTHESIA, hypertensive crises
Слайд 9
Aminazine (Chlorpromazine) -
blocks CNS D2 receptors
α-Recetor
and GANGLIONIC BLOCKADE
? HISTAMINE- and SEROTONIN -mediated
activity.
It has great:
Sedative,
Hypotensive,
Antiallergic,
Anticonvulsant activity
It may produce Galactorrhea (excessive production of milk – due to ?Prolactin release )
Clinical uses: Schizophrenia,
Acute Psychosis in Severely Agitated Patients
Слайд 10
DROPERIDOL amp. 0.25%-10 ml –
a BUTYROPHENONE derivative,
more potent and to have fewer autonomic effects than
other typical neuroleptics.
It blocks subcortical D2 and α-adrenergic receptors, and blocks CNS receptors at the CTZ.
It has no CholinoBlock action.
The drug produces marked sedation and has an antiemetic effect.
IM injection: Sedation begins in 3-10 min,
peaks at 30 min, and lasts for 2-4 hrs.
CLINICAL USE: a drug of choice at
NEUROLEPTANESTHESIA –the combination of neuroleptics with opioid analgesics, FENTANYL.
Anesthetic Premedication,
Maintenance of General Anesthesia.
Слайд 11
Lithium Salts
Lithium Carbonate – Caps. 0.15 and 0.3
g; Tab. 0.3 g
Lithium Citrate – Syrup – 300
mg/5 ml (6% Syrup )
“Anti-Manic” drugs, also considered as “mood-stabilizing” agents because of their primary action of preventing
MOOD SWINGS in patients with
Bipolar Affective (Manic-Depressive) Disorder.
Antimanic Action: antipsychotic and antimanic effects -
by competing with other cations for exchange at
the Na+/ K+ ion pump, thus altering cation exchange
at the tissue level.
? Noradrenaline and Dopamine turnover
Слайд 12
CLINICAL USES
Bipolar Affective Disorders
Major Depression
Schizoaffective Disorder
Alcohol
Dependence
ADVERSE EFFECTS
Psychomotor retardation
Lethargy
Epileptiform seizures
Impaired Speech
Muscle Weakness
Arrhythmias
HYPOTENSION
Dry Mouth
Nausea,
Vomiting
Polyuria
Leukocytosis
Hypothyroidism
Слайд 13
TRANQUILIZERS (ANXIOLYTIC DRUGS)
I. Benzodiazepines (BZDs):
Diazepam (Sibazon )
– amp. 0.5%-2 ml; Tab. 0.005 g
Chlordiazepoxide (Chlozepide) –
Tab. 0.005 g
Nozepam (Oxazepam, Tazepam) – Tab. 0.01 g
Lorazepam – Tab. 1 and 2 mg
Phenasepam – Tab 0.5 and 1 mg
Alprazolam (Xanax) – Tab. 0.25 and 0.5 mg
Mezapam (Rudotel) – Tab. 10 mg
Tofizopam (Grandaxin) – Tab. 50 mg
II. Other Anxiolytics
Buspirone – Tab. 5 and 10 mg
Amyzyl – Tab. 1 and 2 mg
Hydroxyzine – amp. 5%-2 ml; Tab. 10 and 25 mg
Слайд 14
BENZODIAZEPINES
according to their Duration of Action:
1. Long-acting
(24-48 hours):
Diazepam
Phenasepam
Chlordiazepoxide
2. Intermediate-acting (6-24 hours):
Alprazolam
Nozepam
Lorazepam
3.
Short-acting (< 6 hours):
Midazolam (Dormicum)
Gidazepam
Слайд 16
MECHANISM OF ACTION of BZDs:
Bind to the α-subunit
of the GABAA Rs
surrounding the Cl ¯ channels
designated
as BZD Rs (omega-Receptors)
► ? Affinity of GABA Rs
► ? Frequency of Cl ¯ channel opening
► ? Cl ¯ Conductance => Hyperpolarization
=> Post-synaptic Potential away from
its Firing Threshold =>
►Inhibition of Action Potential Formation and
Further Neuronal Firing
Слайд 18
CLINICAL USES of BZDs
1.ANXIETY and PANIC DISORDERS
2. MUSCULAR
DISORDERS:
DIAZEPAM –
⮟ Skeletal Muscle SPASMS in Muscle
Strain
⮟ SPASTICITY from degenerative disorders,
such as Multiple Sclerosis
3. SEIZURES:
CLONAZEPAM – Epilepsy
DIAZEPAM – Grand Mal Epileptic Seizures
Status Epilepticus
CHLORDIAZEPOXIDE, DIAZEPAM,
NOZEPAM (OXAZEPAM) – Alcohol Withdrawal
4. SLEEP DISORDERS
Слайд 19
Psychological and Physical Dependence -
if high
doses are given over a prolonged period
ADVERSE EFFECTS of
BZDs:
DROWSINESS
CONFUSION
ATAXIA
COGNITIVE IMPAIRMENT:
? LONG-TERM RECALL
? ACQUISITION of NEW KNOWLEDGE
Early Morning Insomnia
Daytime anxiety with AMNESIA and CONFUSION
Слайд 20
BZD Antagonist:
FLUMAZENIL –
a GABA receptor
competitive antagonist that can rapidly reverse the effects of
BENZODIAZEPINES.
Blocks actions of BZDs
(and imidazopyridines) but does not antagonize the CNS effects of other sedative-hypnotic, ethanol, opioid, or
general anesthetics
Слайд 21
DIAZEPAM (Sibazon) amp. 0.5%-2 ml; Tab. 0.005 g
is a Tranquilizer, a LONG ACTING BENZODIAZEPINE
MECHANISM OF ACTION:
binds to BDZ receptors, which are separate from but adjacent to the GABA receptors, trigger an opening of a Cl- channel =>
=> ? in Cl- Conductance =>
=>HYPERPOLARIZATION that moves the postsynaptic potential away from its firing threshold and inhibits
the Formation of Action Potentials.
PHARMACOLOGIC EFFECTS: ? anxiety, sedative and hypnotic action, anticonvulsunt and myorelaxant action.
CLINICAL USES: neurotic and neurosis-like conditions with symptoms of anxiety and phobia, increased irritability; epilepsy and status epilepticus, alcohol withdrawal, muscle spasm, as adjunct to anesthesia and endoscopic procedures.
Слайд 22
Gidazepam Tab. 0.02 g; 0.05 g –
DAY
TRANQUILIZER – has ACTIVATING EFFECT
a SHORT ACTING BZD
with anxiolytic, anticonvulsive and weakly expressed myorelaxant action.
It also stabilizes the functions of the Vegetative NS.
MECHANISM OF ACTION:
? the effect of the GABA in the ASCENDING RETICULAR ACTIVATING SYSTEM,=> increases inhibition and
blocks cortical and limbic arousal.
INDICATIONS:
Neurotic and Neurosis-like conditions with symptoms of anxiety and phobia, increased irritability; Acute alcohol withdrawal, Muscle spasm,
Convulsive disorders.
Слайд 23
Busbirone - Tab. 10 mg - an non-BZD
anxiolytic
MECHANISM OF ACTION:
⮟ Blocks 5-HT1A Serotonin receptors and
presynaptic Dopamine receptors
⮟
? Norepinephrine biotransformation
=> Indirect effect on BZD-GABA-CHLORINE receptor complex or GABA receptors
=> has no anticonvulsant or muscle relaxant activity and does not appear to cause physical dependence
The drug is 95% protein-bound;
onset of therapeutic effect may require 1 - 2 weeks.
INDICATIONS:
Anxiety disorders, major depression,
parkinsonian syndrome, premenstrual syndrome,
drug addiction.
Слайд 24
Sedative Drugs:
1. BROMINE SALTS:
Sodium Bromide - NaBr
Potassium
Bromide - KBr
2. VALERIAN’S PREPARATIONS:
(Valeriana officinalis)
Infusion, Tincture, Extract
from
Rhizome and Root of VALERIAN
3. MOTHERWORT’S PREPARATIONS:
(Leonurus cardiaca)
Tincture from Plant Grass
(Tinctura Leonuri)
Mechanism of Action:
⮟ Intensification of slowdown processes in the brain
Clinical Uses: Neurosis
Adverse Efects: Skin Rashes, Sedation,
Behavioral Changes.
Слайд 25
BROMISM – chronic intoxication with BROM salts.
Bromides eliminate
slowly (T1/2=12 days),
MANIFESTATION: total retardation, apathy,
memory disorders,
skin rashes
The IRRITATIVE ACTION of bromides induces
Mucous Inflammations along with
COUGH, RHINITIS, CONJUNCTIVITIS, DIARRHEA.
TREATMENT: the drug should be discontinued and its elimination must be accelerated.
Bromide excretion may be enhanced by using of :
Sodium Chloride, NaCl
abundant drinking, and diuretics (saluretics).
Слайд 26
Valerian’s and Motherwort’s Preparations -
are widely
used sedative drugs.
VALERIAN’S preparations - Infusion, Tincture, Extract
–
are produced from Rhizome and Root of
VALERIANA OFFICINALIS which contain:
valerian acid, organic acids, alkaloids,
tannic substances
MOTHERWORT’S PREPARATIONS - Infusion and Tincture from plant Grass - contain:
ether oils, alkaloids, saponins, tannic substances.
SEDATIVE and WEAK TRANQUILIZING EFFECTS
do not cause myorelaxation, ataxia, psyhologic and physical dependence.
CLINICAL USES: Light Neurosis,
Somatic Diseases with Neurotic Syndrome
ADVERSE EFFECTS: Allergic Reactions.